2/27/2024
04:05 pm
rxrx
Q4/2023 12/31/2023 EPS -0.420 ZacksConsensus -0.460 ActVsEst 0.040 - Beat
Medium
Report
recursion pharmaceuticals, inc. - class a
11/9/2023
07:58 am
rxrx
Q3/2023 9/30/2023 EPS -0.430 ZacksConsensus -0.380 ActVsEst (0.050) - Miss
Medium
Report
recursion pharmaceuticals, inc. - class a
8/8/2023
07:58 am
rxrx
Q2/2023 6/30/2023 EPS -0.380 ZacksConsensus -0.380 ActVsEst 0.000 - In-Line
Medium
Report
recursion pharmaceuticals, inc. - class a
5/8/2023
08:14 am
rxrx
Q1/2023 3/31/2023 EPS -0.340 ZacksConsensus -0.340 ActVsEst 0.000 - In-Line
Low
Report
recursion pharmaceuticals, inc. - class a